Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
C-1027 Aromatized chromophore is the highly potent, active enediyne moiety of the macromolecular antitumor antibiotic C-1027. It is characterized by a nine-membered enediyne core that is responsible for its significant biological activity. Unlike some other enediynes, this molecule is inherently primed for cycloaromatization without external activation, leading to the formation of toxic 1,4-benzenoid diradical species. Its primary mechanism of action involves inducing oxygen-independent interstrand DNA crosslinks, as well as single- and double-stranded DNA breaks, which subsequently inhibit DNA synthesis and cause DNA damage. This unique oxygen-independent mechanism suggests its potential efficacy against hypoxic tumor cells. C-1027 Aromatized chromophore is considered one of the most potent cytotoxic molecules known due to its ability to induce a high ratio of DNA double-strand breaks. The larger C-1027 complex, of which this chromophore is the active component, has been investigated as an anticancer drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on C-1027 Aromatized chromophore.